The development of genetically engineered mouse models (GEMMs) together with the advent of Cre- LoxP technologies and tissue-specific promoters has become excellent tools to assess the functional roles of cancer-associated genes. In recent years, several promoters have been successfully adapted to drive Cre expression specifically within the intestinal epithelium. These promoters have proven useful for manipulating gene expression in normal cells throughout intestinal tract; however, a genetic system that will specifically target intestinal tumors for transgene expression has not yet been developed. Therefore, this exploratory proposal aims to establish a novel mouse model in which the forced expression of a given transgene can be re-introduced through tamoxifen-controlled Cre expression in intestinal tumors. To achieve tumor-specific expression, we will use stearoyl-CoA desaturase (Scd)-3 gene locus as a promoter. We have recently found that Scd3 was consistently up-regulated in intestinal tumors, but not in normal mucosa, suggesting that it may serve as a specific intestinal tumor marker in mice.
In Aim 1, we propose to generate Scd3-CreER+/- mice, and Cre activity is validated using a reporter mice. Optimal timing and duration of Cre activity and the efficiency of Cre-Lox recombination will be determined to establish a viable mouse model.
In Aim 2, we will then characterize the efficiency of Scd3-CreER system in Apc?14/+ tumor model. Finally, in Aim 3, we will extend our analysis to chemically-induced colon cancer model to test the applicability of our Scd3-CreER+/- mice to additional cancer etiologies. We believe that the successful generation of this experimental mouse system will provide a way to test the impact of reactivation of suppressed tumor-associated genes directly within neoplastic tissue, and also enable us to examine the therapeutic effects associated with the functional restoration of the lost genes.

Public Health Relevance

A genetic system to specifically target intestinal tumors for transgene expression has not yet been developed. Proposed studies are aimed at establishing a novel mouse model that will restore functional gene expression directly within cancer cells by inducing Cre-recombinase expression using Scd3 locus as a tumor- specific promoter. Successful generation of this conditional mouse model will make it possible to establish the functional significance of candidate genes and their products as they relate to the etiology, maintenance and progression of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA245602-02
Application #
10070095
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
O'Hayre, Morgan
Project Start
2019-12-11
Project End
2021-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
2
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Connecticut
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
022254226
City
Farmington
State
CT
Country
United States
Zip Code
06030